BioHarvest Sciences Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CNVCF research report →
About the company
BioHarvest Sciences Inc. , along with its subsidiaries, supplies a range of nutraceutical products and medical cannabis to customers both in Israel and globally. The company leverages an innovative plant cell growth technology that allows it to cultivate active secondary metabolites directly from cells, completely circumventing the need to grow the actual plant.
- CEO
- Ilan Sobel
- IPO
- 2021
- HQ
- Vancouver, BC, CA
Price Chart
- Market Cap
- $109.16M
- P/E
- -7.02
- P/S
- 3.85
- P/B
- 68.16
- EV/EBITDA
- -15.68
- Div Yield
- 0.00%
- Gross Margin
- 55.35%
- Op Margin
- -27.75%
- Net Margin
- -51.27%
- ROE
- 190.98%
- ROIC
- -45.32%
- Revenue
- $12.67M · 130.48%
- Net Income
- $-12,564,000 · -11.82%
- EPS
- $-0.93 · -8.14%
- Op Income
- $-9,966,000
- FCF YoY
- 4.77%
- 52W High
- $6.30
- 52W Low
- $6.30
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 1.49
- Avg Volume
- 0
Get TickerSpark's AI analysis on CNVCF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our CNVCF coverage
Recent articles, reports, and earnings notes.
No research on CNVCF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CNVCF report →Similar companies
Peers in the same neighborhood.